- Dividend yield TTM
- 0.00%€0.00/unit
- Dividend growth (CAGR 5Y)
- 107.01%
- Next dividend
Upcoming dividends delivered straight to your inbox
Historical dividends
Tools for dividend investors
Dividend metrics Metrics
All metrics All | Metric | Value |
|---|---|
Price | €3.71 |
Yield | 0.00% |
Interval | Yearly |
CAGR 3Y | 30.64% |
CAGR 5Y | 107.01% |
CAGR 10Y | - |
All dividend data
No dividend has been distributed so far in 2026. In 2025, Wuhan Easy Diagnosis Biomedicine Co Ltd Class A distributed €0.14. The dividend yield is currently 0.00%, and distributions have decreased by 30.64% over the last 3 years. The ETF pays dividends annually.
| Distribution | ||||
|---|---|---|---|---|
| 2025 | €0.14 | 629.55% | 4.10% | |
| 06/12/2025 | 06/12/2025 | €0.14 | ||
| 2024 | €0.0192 | 96.08% | 0.20% | |
| 10/17/2024 | 10/17/2024 | €0.00389 | ||
| 05/28/2024 | 05/28/2024 | €0.0153 | ||
| 2023 | €0.49 | 11.36% | 5.36% | |
| 2022 | €0.44 | 155.22% | 7.34% | |
| 2021 | €0.17 | 4,460.85% | 1.82% | |
| 2020 | €0.00378 | 9.13% | - | |
| 2019 | €0.00416 | 19.69% | - | |
| 2018 | €0.00518 | 0.00% | - | |
Frequently asked questions
What percentage of dividends does Wuhan Easy Diagnosis Biomedicine Co Ltd Class A pay?
Payouts have decreased by 30.64% over the past 3 years.
When were the most recent dividend payment dates for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A?
The most recent payment was made on 06/12/2025. Previous payments were made on: 10/17/2024.
When did you need to hold Wuhan Easy Diagnosis Biomedicine Co Ltd Class A in your portfolio to receive the latest dividend?
If you held Wuhan Easy Diagnosis Biomedicine Co Ltd Class A in your portfolio on 06/12/2025, you received the payout.
How much was the dividend from Wuhan Easy Diagnosis Biomedicine Co Ltd Class A in 2025?
In 2025, Wuhan Easy Diagnosis Biomedicine Co Ltd Class A paid €0.14 in dividends.
How much was the dividend from Wuhan Easy Diagnosis Biomedicine Co Ltd Class A in 2024?
In 2024, Wuhan Easy Diagnosis Biomedicine Co Ltd Class A paid €0.0192 in dividends.